- Home
- PLRX vs SMBK Comparison
PLRX vs SMBK Comparison
Compare PLRX & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- SMBK
- Stock Information
- Founded
- PLRX 2015
- SMBK N/A
- Country
- PLRX United States
- SMBK United States
- Employees
- PLRX N/A
- SMBK N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- SMBK Major Banks
- Sector
- PLRX Health Care
- SMBK Finance
- Exchange
- PLRX Nasdaq
- SMBK Nasdaq
- Market Cap
- PLRX 84.7M
- SMBK 553.9M
- IPO Year
- PLRX 2020
- SMBK N/A
- Fundamental
- Price
- PLRX $1.29
- SMBK $36.08
- Analyst Decision
- PLRX Hold
- SMBK Buy
- Analyst Count
- PLRX 10
- SMBK 5
- Target Price
- PLRX $9.79
- SMBK $34.40
- AVG Volume (30 Days)
- PLRX 1.5M
- SMBK 69.0K
- Earning Date
- PLRX 08-06-2025
- SMBK 07-21-2025
- Dividend Yield
- PLRX N/A
- SMBK 0.90%
- EPS Growth
- PLRX N/A
- SMBK 44.84
- EPS
- PLRX N/A
- SMBK 2.26
- Revenue
- PLRX N/A
- SMBK $171,664,000.00
- Revenue This Year
- PLRX N/A
- SMBK $20.95
- Revenue Next Year
- PLRX N/A
- SMBK $9.48
- P/E Ratio
- PLRX N/A
- SMBK $15.96
- Revenue Growth
- PLRX N/A
- SMBK 16.34
- 52 Week Low
- PLRX $1.10
- SMBK $23.09
- 52 Week High
- PLRX $16.10
- SMBK $37.72
- Technical
- Relative Strength Index (RSI)
- PLRX 38.40
- SMBK 79.16
- Support Level
- PLRX $1.13
- SMBK $33.63
- Resistance Level
- PLRX $1.43
- SMBK $33.23
- Average True Range (ATR)
- PLRX 0.11
- SMBK 0.73
- MACD
- PLRX -0.01
- SMBK 0.37
- Stochastic Oscillator
- PLRX 21.68
- SMBK 98.09
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About SMBK SmartFinancial Inc.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.